nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients
|
Win, Thida |
|
2013 |
41 |
2 |
p. 337-342 |
artikel |
2 |
Author’s comment on the retraction of “Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging”
|
Alavi, Abass |
|
2013 |
41 |
2 |
p. 394 |
artikel |
3 |
Ayfer Haydaroglu, Gokhan Ozygit (eds): Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer
|
Vaccaro, Andrea |
|
2013 |
41 |
2 |
p. 395 |
artikel |
4 |
Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT
|
Kalinyak, Judith E. |
|
2013 |
41 |
2 |
p. 260-275 |
artikel |
5 |
EJNMMI Physics—Access is open for open access
|
Beyer, Thomas |
|
2013 |
41 |
2 |
p. 197-198 |
artikel |
6 |
Erratum to: Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma
|
Salgado Garcia, Carlos |
|
2013 |
41 |
2 |
p. 401 |
artikel |
7 |
Erratum to: Twins in spirit: DOTATATE and high-affinity DOTATATE
|
Brogsitter, Claudia |
|
2013 |
41 |
2 |
p. 402 |
artikel |
8 |
Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours
|
Meyer, Carsten |
|
2013 |
41 |
2 |
p. 231-237 |
artikel |
9 |
[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer’s disease
|
Hatashita, Shizuo |
|
2013 |
41 |
2 |
p. 290-300 |
artikel |
10 |
Five-year follow-up of 11C-PIB uptake in Alzheimer’s disease and MCI
|
Kemppainen, N. M. |
|
2013 |
41 |
2 |
p. 283-289 |
artikel |
11 |
Good clinical practice in pulmonary embolism diagnosis: where do we stand today?
|
Bajc, Marika |
|
2013 |
41 |
2 |
p. 333-336 |
artikel |
12 |
High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT
|
Callahan, Jason |
|
2013 |
41 |
2 |
p. 343-349 |
artikel |
13 |
How smart is peptide receptor radionuclide therapy of neuroendocrine tumors especially in the salvage setting? The clinician’s perspective
|
Prasad, Vikas |
|
2013 |
41 |
2 |
p. 202-204 |
artikel |
14 |
Imaging acute spinal myelitis with 18F-FDG PET/CT
|
Lopci, Egesta |
|
2013 |
41 |
2 |
p. 399-400 |
artikel |
15 |
Improving the dose–myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP
|
Pacilio, Massimiliano |
|
2013 |
41 |
2 |
p. 238-252 |
artikel |
16 |
Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations
|
Yoshinaga, Keiichiro |
|
2013 |
41 |
2 |
p. 384-393 |
artikel |
17 |
Isolated cerebellar metastasis from prostate adenocarcinoma diagnosed by 18F-fluorocholine PET/CT: a rare but not impossible complication
|
Imperiale, Alessio |
|
2013 |
41 |
2 |
p. 397-398 |
artikel |
18 |
131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study
|
Lin, Chien-Mu |
|
2013 |
41 |
2 |
p. 253-259 |
artikel |
19 |
Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicine
|
Verburg, Frederik A. |
|
2013 |
41 |
2 |
p. 199-201 |
artikel |
20 |
Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels
|
Bucerius, Jan |
|
2013 |
41 |
2 |
p. 369-383 |
artikel |
21 |
Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours
|
Sabet, Amir |
|
2013 |
41 |
2 |
p. 205-210 |
artikel |
22 |
Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
|
Hofman, Michael S. |
|
2013 |
41 |
2 |
p. 211-213 |
artikel |
23 |
Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study
|
Abdulla, Sarah |
|
2013 |
41 |
2 |
p. 350-356 |
artikel |
24 |
Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections
|
Erba, P. A. |
|
2013 |
41 |
2 |
p. 357-368 |
artikel |
25 |
Retraction Note: Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging
|
Hayempour, Benjamin Jacob |
|
2013 |
41 |
2 |
p. 403 |
artikel |
26 |
Richard S. Lawson: The Gamma Camera: A Comprehensive Guide
|
Piscopo, Valentina |
|
2013 |
41 |
2 |
p. 396 |
artikel |
27 |
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa
|
Casteels, Cindy |
|
2013 |
41 |
2 |
p. 308-321 |
artikel |
28 |
Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours
|
Romer, A. |
|
2013 |
41 |
2 |
p. 214-222 |
artikel |
29 |
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter
|
Zhang, Hanwen |
|
2013 |
41 |
2 |
p. 322-332 |
artikel |
30 |
Test–retest reliability of [11C]AZ10419369 binding to 5-HT1B receptors in human brain
|
Nord, Magdalena |
|
2013 |
41 |
2 |
p. 301-307 |
artikel |
31 |
The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma
|
Klabatsa, Astero |
|
2013 |
41 |
2 |
p. 276-282 |
artikel |
32 |
Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy
|
Seregni, E. |
|
2013 |
41 |
2 |
p. 223-230 |
artikel |